Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about OPGEN, INC.
01/10OPGEN : Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Upda..
PU
01/10OPGEN : Corporate Presentation (PDF)
PU
2021Opgen Subsidiary Ares Genetics Announces the Strategic Expansion of Aresdb Proprietary ..
CI
2021OPGEN : Announces Results of Special Meeting of Stockholders - Form 8-K
PU
2021OpGen Announces Results of Special Meeting of Stockholders
AQ
2021OPGEN : Corporate Presentation (PDF)
PU
2021OPGEN : Subsidiary Ares Genetics Announces Strategic Database Access Transaction - Form 8-..
PU
2021OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction
GL
2021OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update - Form ..
PU
2021OpGen, Inc. Provides Revenue Guidance for the Year 2021
CI
2021Earnings Flash (OPGN) OPGEN Reports Q3 Revenue $1.2M, vs. Street Est of $1.2M
MT
2021OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
2021OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
2021OpGen Corporate Presentation (PDF)
PU
2021OpGen Appoints Albert Weber as Chief Financial Officer - Form 8-K
PU
2021Executive Video Interview with Oliver Schacht, Ph.D., OpGen CEO - Form 8-K
PU
2021OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number ..
AQ
2021OpGen, Inc. Appoints Albert Weber as Chief Financial Officer, Effective January 1, 2022
CI
2021OPGEN TO PROVIDE BUSINESS UPDATE AND : 30 p.m. Eastern Time
AQ
2021OPGEN : Announces Closing of $15 Million Registered Direct Offering
AQ
2021OPGEN : Announces $15 Million Registered Direct Offering - Form 8-K
PU
2021OPGEN : Launches $15 Million Registered Direct Offering
MT
2021OPGEN : Announces $15 Million Registered Direct Offering
AQ
2021OPGEN : Corporate Presentation (PDF)
PU
2021Wall Street Set for Losses, Supply Chain Woes Dent Sentiment
MT
2021Health Care Stocks Trade Lower Pre-Bell Monday
MT
2021OPGEN : Health Care
MT
2021OPGEN : Receives FDA Clearance for Launch of Acuitas AMR Gene Panel; Provides Preliminary ..
MT
2021OPGEN : Corporate Presentation (PDF)
PU
2021OPGEN : Acuitas« AMR Gene Panel allows testing for a comprehensive panel of 28 genetic AMR..
PU
2021Top Premarket Gainers
MT
2021OpGen, Inc. Reports Unaudited Preliminary Revenue Results for the Third Quarter Ended S..
CI
2021OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Pos..
GL
2021OpGen, Inc. Receives FDA Clearance for Acuitas« AMR Gene Panel
CI
2021OpGen Preliminary 3Q Revenue $1.2 Million; Shares Up 25%
DJ
2021OPGEN : Launches Clinical Trial of Unyvero Urinary Tract Infection Panel
MT
2021OPGEN : Initiates Clinical Trial for Unyvero Urinary Tract Infection Panel
AQ
2021OpGen, Inc. Initiates Clinical Trial for Unyvero Urinary Tract Infection Panel
CI
2021OPGEN : Announces Data from Prospective Randomized Controlled Multicenter Clinical Study U..
AQ
2021OpGen, Inc Announces Clinical Data from Investigator-Initiated and Driven Prospective R..
CI
2021OPGEN : Corporate Presentation (PDF)
PU
2021OPGEN : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 8..
PU
2021Opgen, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
2021OPGEN : Earnings Flash (OPGN) OPGEN Posts Q2 Revenue $811,615
MT
2021OPGEN : Reports Second Quarter 2021 Financial Results and Provides Business Update
AQ
2021OPGEN : Announces the Cancellation of Adjourned Portion of Annual Meeting
AQ
2021OPGEN TO PROVIDE BUSINESS UPDATE AND : 30 p.m. Eastern Time
GL
2021OPGEN : Corporate Presentation (PDF)
PU
2021OPGEN : Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
AQ
2021OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
CI
2021SUPERNUS PHARMACEUTICALS : Pharma Says Named New CFO After Incumbent Resigned to Join Anot..
MT
2021OpGen, Inc. Announces the Resignation of Timothy C. Dec as Chief Financial Officer
CI
2021Opgen, Inc. Announces Resignation of Timothy C. Dec as Corporate Secretary, Effective a..
CI
2021OpGen Announces Partial Adjournment of Annual Meeting
GL
2021OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Pan..
GL
2021OpGen Group Company Ares Genetics Presents R&D Pipeline Updates
GL
2021OPGEN, INC.(NASDAQCM : OPGN) dropped from Russell 3000E Growth Index
CI
2021OPGEN, INC.(NASDAQCM : OPGN) dropped from Russell Microcap Growth Index
CI
2021OPGEN : Thinking about buying stock in Ocugen, Rapt Therapeutics, ContextLogic, OpGen, or ..
PR
2021OPGEN : Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Prop..
PU
2021OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Pro..
GL
2021OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
GL
2021OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Head..
GL
2021OpGen, Inc. Submits Updated 510(k) Summary to FDA For Acuitas AMR Gene Panel for Isolat..
CI
2021OPGEN : Corporate Presentation (PDF)
PU
2021OPGEN : Reports First Quarter 2021 Financial Results and Provides Business Update (Form 8-..
PU
2021Opgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
2021OPGEN : Earnings Flash (OPGN) OPGEN Posts Q1 Loss $-0.50
MT
2021OPGEN : Earnings Flash (OPGN) OPGEN Reports Q1 Revenue $830,000, vs. Street Est of $1.33M
MT
2021OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
GL
2021OPGEN : Corporate Presentation (PDF)
PU
2021OPGEN TO PROVIDE BUSINESS UPDATE AND : 30 a.m. Eastern Time
GL
2021OPGEN : Corporate Presentation (PDF)
PU
2021OpGen Extends and Expands Partnership with New York State Department of Health to Detec..
GL
2021OpGen, Inc. Announces Strategic Collaboration with the New York State Department of Hea..
CI
1  2  3  4  5Next
Upcoming event on OPGEN, INC.